These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3158213)

  • 1. Examination of irreversible platelet-fibrinogen interactions.
    Peerschke EI; Wainer JA
    Am J Physiol; 1985 May; 248(5 Pt 1):C466-72. PubMed ID: 3158213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent association between platelet-bound fibrinogen and the Triton X-100 insoluble cytoskeleton.
    Peerschke EI
    Blood; 1991 Feb; 77(3):508-14. PubMed ID: 1899346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of platelet-fibrinogen interactions: modulation by divalent cations.
    Peerschke EI
    J Lab Clin Med; 1993 Jan; 121(1):135-41. PubMed ID: 8426076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on the effects of cytochalasin B and cytochalasin D on ADP- and chymotrypsin-treated platelets.
    Peerschke EI
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):109-15. PubMed ID: 6694966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of stimulation on the stabilization of platelet-fibrinogen interactions.
    Peerschke EI
    Thromb Haemost; 1992 Sep; 68(3):346-51. PubMed ID: 1440503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between fibrinogen binding to human platelets and platelet aggregability.
    Peerschke EI; Zucker MB; Grant RA; Egan JJ; Johnson MM
    Blood; 1980 May; 55(5):841-7. PubMed ID: 6767512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversibility of fibrinogen fragment D1 binding to human platelets: comparison with native fibrinogen.
    Peerschke EI
    Thromb Res; 1992 Nov; 68(3):259-67. PubMed ID: 1471072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible platelet fibrinogen interactions occur independently of fibrinogen alpha chain degradation and are not mediated by intact platelet membrane glycoprotein IIb-IIIa complexes.
    Peerschke EI
    J Lab Clin Med; 1988 Jan; 111(1):84-92. PubMed ID: 2826623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased accessibility of platelet-bound fibrinogen to antibody and enzyme probes.
    Peerschke EI
    Blood; 1989 Aug; 74(2):682-9. PubMed ID: 2526667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activation by sustained exposure to low-dose plasmin.
    Ervin AL; Peerschke EI
    Blood Coagul Fibrinolysis; 2001 Sep; 12(6):415-25. PubMed ID: 11555694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of actin filament assembly to clearance of fibrinogen gold, GPIIb-IIIa complexes on spread platelets.
    White JG; Burris S; Smith CM
    Eur J Clin Invest; 1995 Apr; 25(4):241-9. PubMed ID: 7541361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets.
    Peerschke EI
    Thromb Haemost; 1995 May; 73(5):862-7. PubMed ID: 7482417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochalasin D and E: effects on fibrinogen receptor movement and cytoskeletal reorganization in fully spread, surface-activated platelets: a correlative light and electron microscopic investigation.
    Olorundare OE; Simmons SR; Albrecht RM
    Blood; 1992 Jan; 79(1):99-109. PubMed ID: 1728321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal ADP-induced aggregation and absence of dissociation of the membrane GP IIb-IIIa complex of intact rat platelets pretreated with EDTA.
    Gachet C; Stierlé A; Ohlmann P; Lanza F; Hanau D; Cazenave JP
    Thromb Haemost; 1991 Aug; 66(2):246-53. PubMed ID: 1771618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.
    Dubernard V; Legrand C
    J Lab Clin Med; 1991 Nov; 118(5):446-57. PubMed ID: 1940585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bound fibrinogen distribution on stimulated platelets. Examination by confocal scanning laser microscopy.
    Peerschke EI
    Am J Pathol; 1995 Sep; 147(3):678-87. PubMed ID: 7677179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.